Items tagged with Treatment
Experts fear a TB epidemic in North Korea amid a crucial medication shortage (post)
(SEOUL) — The withdrawal of a major international aid organization threatens to leave tens of thousands of tuberculosis patients in North Korea without the medication they need and could spiral into a severe crisis if it is not addressed soon, according to health experts familiar with the situation in the North.
India: 400 MDR-TB patients in 7 states to get crucial drug (post)
India gets doses of Delamanid from USAID.
Old TB treatments result in deafness and death (post)
At the Union Conference on Tuberculosis and Lung Disease held in The Hague recently, a well-known European research clinician proclaimed that “countries (with weak health systems) should not let bedaquiline out of the box”.
TB Alliance receives GHTC Partnership Award for development of child-friendly TB medicines (post)
[November 28, 2018, WASHINGTON, D.C.] – TB Alliance and partners were honored today as the winner of the Global Health Technologies Coalition (GHTC) 2018 Innovating for Impact Partnership Award, for the development of improved child-friendly tuberculosis (TB) medicines. Since the improved medicines were introduced in 2016, 85 countries have procured more than 800,000 treatment courses. Appropriately-dosed and palatable, these new medicines are improving TB treatment and survival for the estimated one million children stricken with TB each year.
Patna teen who fought to get TB care in Mumbai, dies (post)
The girl was brought to Mumbai in a state of being unable to breath and with an oxygen cylinder owing to scarring in her lungs. The extreme delay in treatment caused severe damage to her lungs, resulting in her death.
Schrödinger and TB Alliance announce collaboration to accelerate TB drug discovery (post)
Partnership merges Schrödinger’s advanced modeling capabilities with TB Alliance’s expertise in tuberculosis biology to accelerate the development of next-generation treatments
India: Lack of digital ECGs slows roll-out of anti-TB drug (post)
The roll-out of crucial anti-tuberculosis drug, Bedaquiline is slow because of a substantial lack of digital electrocardiogram (ECG) machines on field.
The evolution of TB treatment in India (post)
"... the need of the hour is to expand access to treatment for the most vulnerable subset of multidrug-resistant TB patients and ensure the judicious use of antibiotics in the public and private sector, while maintaining the level of funding required to tackle the growing threat of drug-resistant TB."
Researchers develop new TB treatment (post)
Led by researchers at RCSI (Royal College of Surgeons in Ireland), a team of researchers has developed a new treatment for tuberculosis (TB). This work could offer a practical treatment that has the potential to be scaled-up and mass-produced for clinical testing.
Study sheds more light on delamanid role in treating MDR-TB (post)
A phase 3 trial of delamanid, a newer oral drug for treating multidrug-resistant tuberculosis (MDR-TB), found no statistically significant reduction in time to sputum culture conversion when compared to placebo, but that it was safe and well tolerated.
Page 44 of 108 · Total posts: 0
←First 43 44 45 Last→